These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 5037291

  • 21. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
    Bernardo JF, Murakami S, Branch RA, Sabra R.
    Nephron; 1995; 70(2):235-41. PubMed ID: 7566310
    [Abstract] [Full Text] [Related]

  • 22. Sodium loading treatment for amphotericin B-induced nephrotoxicity.
    Gardner ML, Godley PJ, Wasan SM.
    DICP; 1990 Oct; 24(10):940-6. PubMed ID: 2244408
    [Abstract] [Full Text] [Related]

  • 23. Current and future chemotherapy of central nervous system fungal infections.
    Utz JP.
    Adv Neurol; 1974 Oct; 6():127-32. PubMed ID: 4480013
    [No Abstract] [Full Text] [Related]

  • 24. Intralipid in prophylaxis of amphotericin B nephrotoxicity.
    Vita E, Schroeder DJ.
    Ann Pharmacother; 1994 Oct; 28(10):1182-3. PubMed ID: 7841575
    [No Abstract] [Full Text] [Related]

  • 25. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V, Dromer F, Barge J, Yeni P, Seta N, Molas G, Carbon C.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [Abstract] [Full Text] [Related]

  • 26. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis.
    Kitahara M, Kobayashi GS, Medoff G.
    J Infect Dis; 1976 Jun; 133(6):663-8. PubMed ID: 932494
    [Abstract] [Full Text] [Related]

  • 27. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties.
    Sawaya BP, Briggs JP, Schnermann J.
    J Am Soc Nephrol; 1995 Aug; 6(2):154-64. PubMed ID: 7579079
    [Abstract] [Full Text] [Related]

  • 28. Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.
    Manzoni P, Galletto P, Rizzollo S, Franco C, Gallo E, Antonucci R, Fanos V, Farina D.
    Early Hum Dev; 2012 May; 88 Suppl 2():S86-91. PubMed ID: 22633524
    [Abstract] [Full Text] [Related]

  • 29. Nephrotoxicity in the setting of invasive fungal diseases.
    Ullmann AJ.
    Mycoses; 2008 May; 51 Suppl 1():25-30. PubMed ID: 18471158
    [Abstract] [Full Text] [Related]

  • 30. Clinical approach to renal tubular acidosis in adult patients.
    Reddy P.
    Int J Clin Pract; 2011 Mar; 65(3):350-60. PubMed ID: 21314872
    [Abstract] [Full Text] [Related]

  • 31. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 32. Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
    Ural AU, Avcu F, Cetin T, Beyan C, Kaptan K, Nazaroglu NK, Yalcin A.
    Eur J Clin Pharmacol; 2002 Jan; 57(11):771-3. PubMed ID: 11868798
    [Abstract] [Full Text] [Related]

  • 33. Amphotericin B nephrotoxicity in children.
    Goldman RD, Koren G.
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):421-6. PubMed ID: 15218415
    [Abstract] [Full Text] [Related]

  • 34. Proteinuria lowers the risk of amphotericin B-associated hypokalaemia.
    Mohan S, Ahmed S, Alimohammadi B, Jaitly M, Cheng JT, Pogue VA.
    J Antimicrob Chemother; 2007 Sep; 60(3):690-3. PubMed ID: 17597057
    [Abstract] [Full Text] [Related]

  • 35. Chemotherapy of the systemic mycoses.
    Utz JP.
    Am Fam Physician; 1973 Feb; 7(2):108-14. PubMed ID: 4539760
    [No Abstract] [Full Text] [Related]

  • 36. Amphotericin B nephrotoxicity.
    Raymond JR.
    Am Fam Physician; 1988 Aug; 38(2):199-203. PubMed ID: 3044056
    [Abstract] [Full Text] [Related]

  • 37. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.
    Branch RA.
    Arch Intern Med; 1988 Nov; 148(11):2389-94. PubMed ID: 3056312
    [Abstract] [Full Text] [Related]

  • 38. Lack of nephrotoxicity with the administration of amphotericin B in a lipid emulsion.
    Smith TM, Strozyk WR.
    Ann Pharmacother; 1994 Nov; 28(11):1307-8. PubMed ID: 7849357
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.